The SEC claims Musk cost investors at least $150 million due to the late disclosure and that he harmed any investors who sold ...

The lawsuit accused Musk of misleading shareholders by not reporting his 2022 investment in the social-media company in a ...

The financial regulator ordered Musk to pay a civil penalty and remedies over what is alleged was “unjust enrichment.” ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The SEC alleges Elon Musk violated federal securities law by failing to disclose his more than 5% stake in Twitter on time.

Elon Musk and Vivek Ramasway say they will take aim at $500 billion in federal spending. Hitting their target could risk ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

While talk show queen Oprah Winfrey has declined to name the brand she uses, she’s among the Hollywood stars who have been ...

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

This appointment is a slap in the face to every health care professional who has spent their lives working to protect patients from preventable illness and death,” the letter says.

Tesla CEO Elon Musk caused quite a stir recently when he humorously posed as an Ozempic Santa on Twitter, and gave Ozempic ...